TiQure and Kosin Hospital Begin Metabolic Endoscopy Study
Medical-device startup TiQure and Kosin University Gospel Hospital agreed to jointly study an endoscopic device for obesity, type 2 diabetes and other metabolic diseases.
This article was automatically drafted and passed editorial compliance checks. It synthesizes public source metadata and is not a substitute for individual care or clinical review.
TiQure and Kosin University Gospel Hospital signed a memorandum of understanding on October 1 to begin joint clinical research into a minimally invasive endoscopic approach for metabolic diseases. The hospital's endocrinology professor Kim Bu-kyung will serve as the principal investigator.
What the researchers plan to study
The research will examine duodenal mucosal resurfacing, or DMR. The procedure targets the lining of the duodenum and is intended to stimulate mucosal regeneration, with the goal of improving the metabolic environment and blood-glucose control.
Clinical evidence is still being developed
The partnership marks the start of clinical research, while the stated metabolic and blood-glucose effects remain research goals rather than established outcomes. Patients considering treatment for obesity or type 2 diabetes should discuss currently appropriate options with a qualified clinician.
MediIndex articles are for general information only and are not medical advice, diagnosis, or advertising. Outcomes vary by individual — consult a board-certified specialist for personal decisions.
